- Scrip Originals
Brought to you by
Genocea goes public with $61.4mm
06 Feb 2014
Genocea Biosciences Inc. (developing T cell vaccines for infectious diseases) netted $61.4mm in its initial public offering of 5.5mm common shares at $12 each, the low end of its proposed $12-14 range.
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com